<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016072629078N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-10-08</date_registration>
      <primary_sponsor>Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effects of Traditional medicine product in Diabetic Foot Ulcer</public_title>
      <acronym></acronym>
      <scientific_title>The effect of Aloe vera and Plantago Major gel in Diabetic Foot Ulcers in patients with type 2 diabetes.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/23454</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Diabetic Foot Ulcer.</hc_freetext>
      <i_freetext>Intervention 1: In the control group, placebo topical (gel containing only basis) also trained twice a day by the patient or the patient up to 28 days to five millimeters in diameter is applied on the wound and finally covered with sterile gauze and tape is latex-free. Intervention 2: In the intervention group Aloe vera 10% gel and Hydroalcholic extract of leave of Plantago Major (Aloe Vera 5% resin and Plantago Major 5% extract ) with trained twice a day by the patient or the patient up to 28 days to five millimeters in diameter is applied on the wound and finally covered with sterile gauze and tape is latex-free.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Yones Najafian Razavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>East Razi Ave, Opposite the Mehran sports hall, Faculty of Iranian Traditional Medicine and Complementary</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 51338552188</telephone>
        <email>najafiany921@mums.ir; yones_dr@yahoo.com</email>
        <affiliation>Faculty of Iranian Traditional Medicine and Complementary of Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zohre Feyzabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>East Razi Ave, Opposite the Mehran sports hall, Faculty of Iranian Traditional Medicine and Complementary</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 51 3855 2188</telephone>
        <email>Feyzabadiz@mums.ac.ir</email>
        <affiliation>Faculty of Iranian Traditional Medicine and Complementary of Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: Type II diabetes for at least 5 years; Age between 30 to 65 years; BMI greater than 18 and less than 35; Diagnosis of neuropathic diabetic foot ulcer Wagner grade 1 or 2 Moderate infection by Internal expert; HbA1C &lt;10; Exclusion criteria: Lack of patient follow-up; Lack of satisfaction in every stage of the study; Failure to respond to treatment; Create complications in the study conducted by treatment; Acute or severe complications of diabetes, exacerbation of underlying disease; Other systemic diseases ; Tobacco, Alcohol, Cytotoxic, Glucocorticoid, Immunosuppressive drugs; Pregnancy and lactation; Sensitivity to Aloe vera and Plantago Major plants; Diabetic foot ulcer grade 3 to 5 Wagner; Suspected osteomyelitis ( lesion size of more than 2 square centimeters )</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E10.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Insulin-dependent diabetes mellitus with peripheral circulatory complications</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the control group, placebo topical (gel containing only basis) also trained twice a day by the patient or the patient up to 28 days to five millimeters in diameter is applied on the wound and finally covered with sterile gauze and tape is latex-free.</i_keyword>
      <i_keyword>In the intervention group Aloe vera 10% gel and Hydroalcholic extract of leave of Plantago Major (Aloe Vera 5% resin and Plantago Major 5% extract ) with trained twice a day by the patient or the patient up to 28 days to five millimeters in diameter is applied on the wound and finally covered with sterile gauze and tape is latex-free.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The area of ​​the wound. Timepoint: Baseline, the end of the study. Method of measurement: Ruler and Imaging.</prim_outcome>
      <prim_outcome>Deep wounds. Timepoint: Baseline, the end of the study. Method of measurement: A sterile swab.</prim_outcome>
      <prim_outcome>Wound  symptoms. Timepoint: Baseline, the end of the study. Method of measurement: Secretion, Edema, Erythema And Desquamation.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>HbA1c. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
      <sec_outcome>Urea. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
      <sec_outcome>2Hpp. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
      <sec_outcome>CBC. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
      <sec_outcome>FBS. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
      <sec_outcome>Blood pressure. Timepoint: Baseline, the end of the study. Method of measurement: Manometer.</sec_outcome>
      <sec_outcome>Creatinine. Timepoint: Baseline, the end of the study. Method of measurement: Laboratory blood test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Research and Technology Vice-Chancellory of Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-06-18</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Daneshgah Ave, Building Qureshi, Mashhad University of Medical Sciences Administration Mashhad  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
